Yüklüyor......
Preliminary study of the efficacy of xamoterol in bradycardia-tachycardia syndrome.
Following 4 weeks on placebo, eighteen patients with bradycardia-tachycardia syndrome (BTS) were treated with 100 mg xamoterol twice daily for 2-4 weeks. Ambulatory 24 h Holter electrocardiogram recordings showed that xamoterol decreased maximum heart rate from 140 +/- 5.1 to 107 +/- 6 beats min-1 (...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1364804/ https://ncbi.nlm.nih.gov/pubmed/7826834 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|